2,751–2,800 of 20,598 genesranked by Most Researched
| # | Gene | Name | Chr | Tags | PubMed Papers |
|---|---|---|---|---|---|
| 2751 | ESYT1 | extended synaptotagmin 1 | 12 | TransporterExperimental GO Evidence | 163 |
| 2752 | FABP1 | fatty acid binding protein 1 | 2 | TransporterExperimental GO Evidence | 163 |
| 2753 | H4C9 | H4 clustered histone 9 | 6 | Hub GeneSwiss-Prot Reviewed | 163 |
| 2754 | HLTF | helicase like transcription factor | 3 | DNA RepairTrending | 163 |
| 2755 | KIR2DS2 | killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 | 19 | ReceptorExperimental GO Evidence | 163 |
| 2756 | LAG3 | lymphocyte activating 3 | 12 | Hub GeneFDA Approved Target | 163 |
| 2757 | MYCBP2 | MYC binding protein 2 | 13 | Highly ConstrainedExperimental GO Evidence | 163 |
| 2758 | MYO7A | myosin VIIA | 11 | OMIM Disease GeneVariant-Rich | 163 |
| 2759 | NCF2 | neutrophil cytosolic factor 2 | 1 | OMIM Disease GeneVariant-Rich | 163 |
| 2760 | PDK1 | pyruvate dehydrogenase kinase 1 | 2 | KinaseClinical Trials | 163 |
| 2761 | PRDX5 | peroxiredoxin 5 | 11 | TrendingExperimental GO Evidence | 163 |
| 2762 | PTGER2 | prostaglandin E receptor 2 | 14 | ReceptorFDA Approved Target | 163 |
| 2763 | PYCR1 | pyrroline-5-carboxylate reductase 1 | 17 | OMIM Disease GeneTrending | 163 |
| 2764 | TXNDC5 | thioredoxin domain containing 5 | 6 | Experimental GO EvidenceSwiss-Prot Reviewed | 163 |
| 2765 | CPSF7 | cleavage and polyadenylation specific factor 7 | 11 | Highly ConstrainedExperimental GO Evidence | 162 |
| 2766 | DHCR24 | 24-dehydrocholesterol reductase | 1 | Early PipelineOMIM Disease Gene | 162 |
| 2767 | EXO1 | exonuclease 1 | 1 | DNA RepairHub Gene | 162 |
| 2768 | FOXK1 | forkhead box K1 | 7 | Transcription FactorTrending | 162 |
| 2769 | GRIA1 | glutamate ionotropic receptor AMPA type subunit 1 | 5 | Hub GeneIon Channel | 162 |
| 2770 | MS4A1 | membrane spanning 4-domains A1 | 11 | FDA Approved TargetOMIM Disease Gene | 162 |
| 2771 | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 6 | Experimental GO EvidenceSwiss-Prot Reviewed | 162 |
| 2772 | NEU1 | neuraminidase 1 | 6 | OMIM Disease GeneVariant-Rich | 162 |
| 2773 | NPHS1 | NPHS1 adhesion molecule, nephrin | 19 | OMIM Disease GeneVariant-Rich | 162 |
| 2774 | NRF1 | nuclear respiratory factor 1 | 7 | Highly ConstrainedTrending | 162 |
| 2775 | PTGES | prostaglandin E synthase | 9 | Experimental GO EvidenceSwiss-Prot Reviewed | 162 |
| 2776 | RNASEL | ribonuclease L | 1 | OMIM Disease GeneExperimental GO Evidence | 162 |
| 2777 | RPS28 | ribosomal protein S28 | 19 | Hub GeneFDA Approved Target | 162 |
| 2778 | SLC1A3 | solute carrier family 1 member 3 | 5 | TransporterOMIM Disease Gene | 162 |
| 2779 | TBXA2R | thromboxane A2 receptor | 19 | ReceptorFDA Approved Target | 162 |
| 2780 | TICAM1 | TIR domain containing adaptor molecule 1 | 19 | OMIM Disease GeneExperimental GO Evidence | 162 |
| 2781 | TNFRSF9 | TNF receptor superfamily member 9 | 1 | Hub GeneReceptor | 162 |
| 2782 | UIMC1 | ubiquitin interaction motif containing 1 | 5 | DNA RepairExperimental GO Evidence | 162 |
| 2783 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | 22 | TrendingExperimental GO Evidence | 161 |
| 2784 | CCL18 | C-C motif chemokine ligand 18 | 17 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2785 | CD99 | CD99 molecule (Xg blood group) | X|Y | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2786 | CDC25B | cell division cycle 25B | 20 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2787 | COIL | coilin | 17 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2788 | DLL4 | delta like canonical Notch ligand 4 | 15 | Highly ConstrainedClinical Trials | 161 |
| 2789 | EPHX2 | epoxide hydrolase 2 | 8 | Clinical TrialsExperimental GO Evidence | 161 |
| 2790 | ETFA | electron transfer flavoprotein subunit alpha | 15 | TransporterOMIM Disease Gene | 161 |
| 2791 | FAU | FAU ubiquitin like and ribosomal protein S30 fusion | 11 | Highly ConstrainedHub Gene | 161 |
| 2792 | GABRA1 | gamma-aminobutyric acid type A receptor subunit alpha1 | 5 | Highly ConstrainedIon Channel | 161 |
| 2793 | MT2A | metallothionein 2A | 16 | TrendingExperimental GO Evidence | 161 |
| 2794 | NR2F2 | nuclear receptor subfamily 2 group F member 2 | 15 | Highly ConstrainedReceptor | 161 |
| 2795 | POLR1C | RNA polymerase I and III subunit C | 6 | Hub GeneOMIM Disease Gene | 161 |
| 2796 | PSMD9 | proteasome 26S subunit, non-ATPase 9 | 12 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2797 | SEC61B | SEC61 translocon subunit beta | 9 | Hub GeneTransporter | 161 |
| 2798 | SRSF10 | serine and arginine rich splicing factor 10 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2799 | TMEM33 | transmembrane protein 33 | 4 | Experimental GO EvidenceSwiss-Prot Reviewed | 161 |
| 2800 | VDAC3 | voltage dependent anion channel 3 | 8 | TransporterTrending | 161 |